Skip to main content
. 2018 Apr 29;5(3-4):109–119. doi: 10.18632/oncoscience.413

Figure 3. Non-selective β-AR antagonists increase PSF and OS in patients with metastatic angiosarcoma.

Figure 3

Patients with an initial diagnosis of metastatic angiosarcoma were prescribed the non-selective beta blockers propranolol (n=8) or carvedilol (n=1) in addition to their standard anti-cancer treatment regimen. PFS (A) and OS (B) were tracked between the years of 2013 to 2017.